BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37498055)

  • 1. Molecule Flips Switch on Gene Regulation.
    Cancer Discov; 2023 Sep; 13(9):1952-1953. PubMed ID: 37498055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feedback loop of LITAF and BCL6 is involved in regulating apoptosis in B cell non-Hodgkin's-lymphoma.
    Shi Y; Kuai Y; Lei L; Weng Y; Berberich-Siebelt F; Zhang X; Wang J; Zhou Y; Jiang X; Ren G; Pan H; Mao Z; Zhou R
    Oncotarget; 2016 Nov; 7(47):77444-77456. PubMed ID: 27764808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted epigenetic repression of a lymphoma oncogene by sequence-specific histone modifiers induces apoptosis in DLBCL.
    Luo H; Schmidt JA; Lee YS; Oltz EM; Payton JE
    Leuk Lymphoma; 2017 Feb; 58(2):445-456. PubMed ID: 27268204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6.
    Palomero J; Vegliante MC; Eguileor A; Rodríguez ML; Balsas P; Martínez D; Campo E; Amador V
    Leukemia; 2016 Jul; 30(7):1596-9. PubMed ID: 26710884
    [No Abstract]   [Full Text] [Related]  

  • 5. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
    Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
    Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential transcription factor targeting for diffuse large B-cell lymphomas.
    Cerchietti LC; Polo JM; Da Silva GF; Farinha P; Shaknovich R; Gascoyne RD; Dowdy SF; Melnick A
    Cancer Res; 2008 May; 68(9):3361-9. PubMed ID: 18451163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaiso is a key regulator of spleen germinal center formation by repressing Bcl6 expression in splenocytes.
    Koh DI; Yoon JH; Kim MK; An H; Kim MY; Hur MW
    Biochem Biophys Res Commun; 2013 Dec; 442(3-4):177-82. PubMed ID: 24269670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].
    Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI
    Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 10. UHRF1 downregulation promotes T follicular helper cell differentiation by increasing BCL6 expression in SLE.
    Liu L; Hu L; Yang L; Jia S; Du P; Min X; Wu J; Wu H; Long H; Lu Q; Zhao M
    Clin Epigenetics; 2021 Feb; 13(1):31. PubMed ID: 33568199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival.
    Lu X; Fernando TM; Lossos C; Yusufova N; Liu F; Fontán L; Durant M; Geng H; Melnick J; Luo Y; Vega F; Moy V; Inghirami G; Nimer S; Melnick AM; Lossos IS
    Blood; 2018 Nov; 132(19):2026-2039. PubMed ID: 30082494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.
    Ye BH; Chaganti S; Chang CC; Niu H; Corradini P; Chaganti RS; Dalla-Favera R
    EMBO J; 1995 Dec; 14(24):6209-17. PubMed ID: 8557040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
    Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
    Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas.
    Walker SR; Nelson EA; Frank DA
    Oncogene; 2007 Jan; 26(2):224-33. PubMed ID: 16819511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo.
    Richter A; Sender S; Lenz A; Schwarz R; Hinz B; Knuebel G; Sekora A; Murua Escobar H; Junghanss C; Roolf C
    BMC Cancer; 2020 Mar; 20(1):184. PubMed ID: 32131762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cells.
    Ujvari D; Nagy N; Madapura HS; Kallas T; Kröhnke MCL; Stenke L; Klein E; Salamon D
    Biochem Biophys Res Commun; 2018 Apr; 498(3):502-508. PubMed ID: 29510136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma.
    Wu WR; Lin JT; Pan CT; Chan TC; Liu CL; Wu WJ; Sheu JJ; Yeh BW; Huang SK; Jhung JY; Hsiao MS; Li CF; Shiue YL
    Theranostics; 2020; 10(2):707-724. PubMed ID: 31903146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy.
    Fabre MS; Stanton NM; Slatter TL; Lee S; Senanayake D; Gordon RMA; Castro ML; Rowe MR; Taha A; Royds JA; Hung N; Melnick AM; McConnell MJ
    PLoS One; 2020; 15(4):e0231470. PubMed ID: 32320427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.
    Fan Q; Meng X; Liang H; Zhang H; Liu X; Li L; Li W; Sun W; Zhang H; Zen K; Zhang CY; Zhou Z; Chen X; Ba Y
    Protein Cell; 2016 Dec; 7(12):899-912. PubMed ID: 27815824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas.
    Baron BW; Anastasi J; Bies J; Reddy PL; Joseph L; Thirman MJ; Wroblewski K; Wolff L; Baron JM
    Blood Cells Mol Dis; 2014 Jan; 52(1):68-75. PubMed ID: 23910958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.